Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Multiplex Detection Immunoassays Market, By Assay Type
7.1. Multiplex Detection Immunoassays Market, by Assay Type, 2021-2030
7.1.1. Planar Assay
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Blends Protein Arrays (Multiplexed ELISA)
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Antibody Arrays
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Bead-based Assay
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Magnetic Bead-based
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Non-magnetic Bead-based
7.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Multiplex Detection Immunoassays Market, By Technique
8.1. Multiplex Detection Immunoassays Market, by Technique, 2021-2030
8.1.1. Nucleic Acid-based Techniques
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Protein-based Techniques
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biosensor-based Techniques
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Multiplex Detection Immunoassays Market, By Application
9.1. Multiplex Detection Immunoassays Market, by Application, 2021-2030
9.1.1. Disease Testing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Infectious Disease Testing
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Autoimmune Disease Testing
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Other Diseases Testing
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Food Contamination Testing
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Research & Development
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Veterinary Disease Testing
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Multiplex Detection Immunoassays Market, By End User
10.1. Multiplex Detection Immunoassays Market, by End User, 2021-2030
10.1.1. Pharmaceutical & Biopharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Clinical Research Organizations
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Food & Beverages Industry
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Academic & Research Institutes
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Diagnostic Centers
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Multiplex Detection Immunoassays Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. Market Revenue and Forecast, by End User (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Technique (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Assay Type (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Technique (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 12. Company Profiles
12.1. Hoffmann-La Roche Ltd.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. QIAGEN
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck KGaA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Microsynth AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Luminex Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Becton
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Dickinson and Company
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms